News & Events

in this report on Form 8-K is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and such information shall not be deemed incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On April 6, 2026, Matthew McBrady notified the Board of Directors (the “Board”) of Axon Enterprise, Inc. (the “Company”) that he will not stand for re-election as a director at the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”). Mr. McBrady will continue to serve as a director until his term expires at the Annual Meeting. Mr.…

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 5, 2026, Julie Anne Cullivan notified the Board of Directors (the “Board”) of Axon Enterprise, Inc. (the “Company”) that she will not stand for re-election as a director at the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”). Ms. Cullivan will continue to serve as a director until her term expires at the Annual Meeting…

in this report on Form 8-K is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and such information shall not be deemed incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Other Events Pursuant to a notice of redemption dated December 18, 2025, in respect of the 0.50% convertible senior notes due 2027 (the “Convertible Notes”) of Axon Enterprise, Inc. (the “Company”), the Company redeemed $840,000 aggregate principal amount of Convertible Notes on February 10, 2026, with cash, at a redemption price equal to 100% of the principal amount thereof, together with accrued and unpaid interest to, but excluding, February 10, 2026. Further, pursuant to the notice of red…

Other Events On December 18, 2025, Axon Enterprise, Inc. (the “Company”) delivered a notice of redemption in respect of the Company’s 0.50% convertible senior notes due 2027 (the “Notes”). Pursuant to the notice of redemption, the Company has elected to redeem all of the outstanding Notes on February 10, 2026 (the “Redemption Date”), at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, together with accrued and unpaid interest on the Notes redeemed to, but…

Other Events On December 18, 2025, Axon Enterprise, Inc. (the “Company”) delivered a notice of redemption in respect of the Company’s 0.50% convertible senior notes due 2027 (the “Notes”). Pursuant to the notice of redemption, the Company has elected to redeem all of the outstanding Notes on February 10, 2026 (the “Redemption Date”), at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, together with accrued and unpaid Interest on the Notes redeemed to, but…

by reference, insofar as it relates to the unregistered sales of equity securities.

Other Events On December 16, 2025, the Company closed the separate, privately negotiated exchange transactions referenced in the Original 8-K (collectively, the “Exchange Transactions”) with certain holders (the “Holders”) of its 0.50% Convertible Senior Notes due 2027 (the “Notes”), including an additional $19,000,000 aggregate principal amount of Notes exchanged pursuant to a separate, privately negotiated exchange agreement entered into with a Holder on December 15, 2025, subsequent to the…

by reference, insofar as it relates to the unregistered sales of equity securities.

Other Events On December 9, 2025, Axon Enterprise, Inc. (the “Company”) entered into separate, privately negotiated agreements (the “Exchange Agreements”) with certain holders (the “Holders”) of the Company’s 0.50% convertible senior notes due 2027 (the “Notes”). Pursuant to these Exchange Agreements, the Company and the Holders have agreed, subject to customary closing conditions, to exchange approximately $177.9 million aggregate principal amount of the Notes for exchange consideration cons…

in this report on Form 8-K is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and such information shall not be deemed incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 28, 2025, Todd Morgenfeld was appointed to the Board of Directors (the “Board”) of Axon Enterprise, Inc. (the “Company”) effective immediately. The Board also appointed him to serve on the Audit Committee and Mergers and Acquisitions and Capital Structure Committee, commencing concurrently with his Board service. Mr. Morgenfeld is an inde…

in this report on Form 8-K is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and such information shall not be deemed incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review On May 1, 2025, the Audit Committee (the “Audit Committee”) of the Board of Directors (the “Board”) of the Company, in consultation with management, concluded that the following previously issued consolidated financial statements of the Company (and related earnings releases, press releases, shareholder communications, investor presentations or other materials describing relevant porti…

in this report on Form 8-K is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and such information shall not be deemed incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Other Events On March 13, 2025, the Company closed the separate, privately negotiated exchange transactions disclosed in the Original 8-K (collectively, the “Exchange Transactions”) with certain holders (the “Holders”) of its 0.50% Convertible Senior Notes due 2027 (the “Notes”). In the Exchange Transactions, Holders exchanged $407,453,000 in aggregate principal amount of the Notes for an aggregate principal amount of $407,954,826.34 in cash (inclusive of accrued interest and fractional share…

by reference, insofar as it relates to the unregistered sales of equity securities.

Entry into a Material Definitive Agreement Indenture On March 11, 2025, Axon Enterprise, Inc. (the “Company”) closed its previously announced private offering (the “Notes Offering”) of $1,000.0 million aggregate principal amount of its 6.125% senior notes due 2030 (the “2030 Notes”) and $750.0 million aggregate principal amount of its 6.250% senior notes due 2033 (the “2033 Notes” and, together with the 2030 Notes, the “Notes”). Each series of Notes were issued pursuant to an indenture, each…

Other Events On March 5, 2025, the Company issued a press release announcing the pricing of the Notes Offering. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein. The press release includes forward-looking statements. See “Cautionary Note Regarding Forward-Looking Information” within the press release for additional information.

Other Events On March 6, 2025, Axon Enterprise, Inc. (the “Company”) entered into separate, privately negotiated agreements (the “Exchange Agreements”) with certain holders (the “Holders”) of the Company’s 0.50% convertible senior notes due 2027 (the “Notes”). Pursuant to these Exchange Agreements, the Company and the Holders have agreed, subject to customary closing conditions, to exchange approximately $407.5 million aggregate principal amount of the Notes for exchange consideration consist…

by reference, insofar as it relates to the unregistered sales of equity securities.

Other Events Notes Offering On March 5, 2025, Axon Enterprise, Inc. (the “Company”) announced that it intends to offer, subject to market and other condition s, $1,500.0 million aggregate principal amount of its senior notes, comprising senior notes due 2030 (the “2030 Notes”) and senior notes due 2033 (the “2033 Notes” and, together with the 2030 Notes, the “Notes”). A copy of the press release announcing the offering is attached hereto as Exhibit 99.1 and is incorporated herein by reference…

Results of Operations and Financial Condition O n February 25, 2025, Ax on Enterprise, Inc. (the “Company” or “Axon”) issued a shareholder letter regarding the Company’s financial results for the three and twelve months ende d December 31, 2024. Th e full text of the letter is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The information pursuant to

Results of Operations and Financial Condition On November 7, 2024, Axon Enterprise, Inc. (the “Company” or “Axon”) issued a shareholder letter regarding the Company’s financial results for its third quarter ended September 30, 2024. The full text of the letter, together with the audited consolidated statements of operations, segment reporting, balance sheets, cash flow information, statistical measures and reconciliations of GAAP to non-GAAP financial measures are attached hereto as Exhibit 9…